Taipei Veterans General Hospital (TVGH) inaugurated its heavy ion therapy facility on May 15 this year, completing treatment for 100 patients within six months as of today (Dec. 5). TVGH Superintendent Chen Wei-ming noted that pancreatic cancer—previously considered untreatable—can now be surgically removed following chemotherapy and heavy ion therapy. Other conditions, including prostate, lung, liver,
Taipei Veterans General Hospital launched its heavy ion therapy service on May 15 this year, completing treatment for 100 patients within six months as of today (12/5). According to stats from the hospital, the top four cancers treated with heavy ion therapy over the past six months are prostate cancer, pancreatic cancer, liver cancer, and
RevoCart Surgery Services Description: RevoCart surgery service is a minimally invasive procedure that utilizes autologous cartilage processed through physical and chemical treatment to activate chondrocytes, combined with a bioresorbable biphasic scaffold (mimicking cartilage and subchondral bone). Implanted via arthroscopy or a minimally invasive incision, it enables cartilage regeneration and repair. The procedure takes
Taiwan’s First Exablate Case Relieves Parkinson’s Tremor Symptoms! In November 2018, the Exablate Center performed a treatment to relieve symptoms in a patient suffering from Parkinson’s tremors. Post-surgery, the patient’s resting tremor in the left hand was successfully alleviated. Now, when dining out and joining social gatherings, they can finally feel more confident and no
Loss of Appetite Turn Out to Be Pancreatic Cancer: Concurrent Proton and Chemotherapy Achieves a Turnaround! In October last year, 57-year-old Ms. Chen suffered from a loss of appetite, losing nearly 10 kilograms within three months. After seeking medical attention at Taipei Veterans General Hospital, she was diagnosed with Stage III pancreatic cancer. However, because
Inner Mongolia Man Finds New Life Through Proton Therapy After Post-Surgery Lung Cancer Metastasis Just when a patient believes they have escaped the threat of death after undergoing difficult surgery, realizing that the disease is still lingering comes as the biggest shock. This situation is often the most agonizing for both the patient and the
Xiao Chen (pseudonym), a 35-year-old male and a prominent lawyer from Malaysia, traveled to Taiwan for nasopharyngeal carcinoma treatment. Facing a second recurrence of nasopharyngeal carcinoma, he was cautious. Through online searches and extensive inquiries, he learned that Taiwan has vast experience treating nasopharyngeal carcinoma patients, rendering it almost as routine as managing a common
